Clinical Trials Directory

Trials / Completed

CompletedNCT02335073

Effect of 4 Liver Fibrosis Tests (PIIINP, CIV, LN, and HA) on the Prognosis of Liver Cirrhosis

Effect of 4 Liver Fibrosis Tests (PIIINP, CIV, LN, and HA) on the Prognosis of Liver Cirrhosis: A Single-center, Prospective, Observational Study

Status
Completed
Phase
Study type
Observational
Enrollment
108 (actual)
Sponsor
General Hospital of Shenyang Military Region · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Liver biopsy is the reference method for the measurement of liver fibrosis. But it has many limitations, such as sampling error and individual variation in interpreting the results. Currently, serum liver fibrosis markers have been employed as non-invasive diagnosis of liver fibrosis and evaluation of the severity of liver fibrosis. They include laminin (LN), hyaluronic acid (HA), collagen type IV (CIV), and N-terminal propeptide of collagen III (PIIINP). However, few study was conducted to explore the role of these liver fibrosis markers in evaluating the prognosis of liver cirrhosis. Our hypothesis is that LN, HA, CIV, and PIIINP in combination or alone can predict the prognosis of liver cirrhosis.

Conditions

Interventions

TypeNameDescription
OTHERVenous blood

Timeline

Start date
2015-01-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2015-01-09
Last updated
2024-02-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02335073. Inclusion in this directory is not an endorsement.

Effect of 4 Liver Fibrosis Tests (PIIINP, CIV, LN, and HA) on the Prognosis of Liver Cirrhosis (NCT02335073) · Clinical Trials Directory